Advanced Cell Technology, Inc. Share Price OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

10/16/10	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/16/22	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/15/28	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/15/03	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
25/15/25	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	03/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-1.90%	+2.85%	+61.37%	+102.88%	7.01TCr
ARGENX SE	-3.21%	-4.32%	+31.19%	+59.75%	5.29TCr
INSMED INCORPORATED	-2.05%	-5.61%	-3.14%	+454.89%	2.7TCr
WUXI BIOLOGICS (CAYMAN) INC.	-1.27%	-1.57%	+46.46%	+6.09%	2.36TCr
BIONTECH SE	+1.05%	-0.62%	-17.40%	-13.36%	2.34TCr
PHARMAESSENTIA CORPORATION	+3.81%	+20.97%	+263.48%	+552.47%	1.94TCr
GENMAB A/S	+0.10%	+1.40%	+38.98%	-20.04%	1.87TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.95%	-3.52%	+20.04%	+613.01%	1.59TCr
EXELIXIS, INC.	+1.24%	-5.23%	+33.19%	+138.21%	1.27TCr
Average	-0.35%	+1.95%	+52.69%	+210.43%	2.93TCr
Weighted average by Cap.	-1.09%	+0.55%	+49.85%	+168.09%

Employees

Sector